Mass Measurement of 27^{27}P for Improved Type-I X-ray Burst Modeling

Light curves are the primary observable of type-I x-ray bursts. Computational x-ray burst models must match simulations to observed light curves. Most of the error in simulated curves comes from uncertainties in $rp$ process reaction rates, which can be reduced via precision mass measurements of neutron-deficient isotopes in the $rp$ process path. We perform a precise atomic mass measurement of $^{27}$P and use this new measurement to update existing type-I x-ray burst models to produce an improved light curve. High-precision Penning trap mass spectrometry was used to determine the atomic mass of $^{27}$P. Modules for Experiments in Stellar Astrophysics (MESA) was then used to simulate x-ray bursts using a 1D multi-zone model to produce updated light curves. The mass excess of $^{27}$P was measured to be -670.7$\pm$ 0.6 keV, a fourteen-fold precision increase over the mass reported in AME2020. The $^{26}$Si($p, \gamma$)$^{27}$P and reverse photodisintegration reaction rates have been determined to a higher precision based on the new, high precision mass measurement of $^{27}$P, and MESA light curves generated using these rates. Changes in the mass of $^{27}$P seem to have minimal effect on XRB light curves, even in burster systems tailored to maximize impact. The mass of $^{27}$P does not play a significant role in x-ray burst light curves. It is important to understand that more advanced models don't just provide more precise results, but often qualitatively different ones. This result brings us a step closer to being able to extract stellar parameters from individual x-ray burst observations. In addition, the Isobaric Multiplet Mass Equation (IMME) has been validated for the $A=27, T=3/2$ quartet, but only after including a small, theoretically predicted cubic term and utilizing an updated excitation energy for the $T=3/2$ isobaric analogue state of $^{27}$Si.Comment: 8 pages, 7 figure

Investigating nuclear structure near N=32 and N=34: Precision mass measurements of neutron-rich Ca, Ti, and V isotopes

Nuclear mass measurements of isotopes are key to improving our understanding of nuclear structure across the chart of nuclides, in particular, for the determination of the appearance or disappearance of nuclear shell closures. We present high-precision mass measurements of neutron-rich Ca, Ti, and V isotopes performed at TRIUMF's Ion Trap for Atomic and Nuclear science (TITAN) and the Low Energy Beam and Ion Trap (LEBIT) facilities. These measurements were made using the TITAN multiple-reflection time-of-flight mass spectrometer (MR-ToF-MS) and the LEBIT 9.4T Penning trap mass spectrometer. In total, 13 masses were measured, 8 of which represent increases in precision over previous measurements. These measurements refine trends in the mass surface around N=32 and N=34, and support the disappearance of the N=32 shell closure with increasing proton number. Additionally, our data do not support the presence of a shell closure at N=34.Nuclear mass measurements of isotopes are key to improving our understanding of nuclear structure across the chart of nuclides, in particular for the determination of the appearance or disappearance of nuclear shell closures. We present high-precision mass measurements of neutron-rich Ca, Ti and V isotopes performed at the TITAN and LEBIT facilities. These measurements were made using the TITAN multiple-reflection time-of-flight mass spectrometer (MR-ToF-MS) and the LEBIT 9.4T Penning trap mass spectrometer. In total, 13 masses were measured, eight of which represent increases in precision over previous measurements. These measurements refine trends in the mass surface around $N = 32$ and $N = 34$, and support the disappearance of the $N = 32$ shell closure with increasing proton number. Additionally, our data does not support the presence of a shell closure at $N = 34$

Elastic Stable Intramedullary Nailing (ESIN), Orthoss® and Gravitational Platelet Separation - System (GPS®): An effective method of treatment for pathologic fractures of bone cysts in children

<p>Abstract</p> <p>Background</p> <p>The different treatment strategies for bone cysts in children are often associated with persistence and high recurrence rates of the lesions. The safety and clinical outcomes of a combined mechanical and biological treatment with elastic intramedullary nailing, artificial bone substitute and autologous platelet rich plasma are evaluated.</p> <p>Methods</p> <p>From 02/07 to 01/09 we offered all children with bone cysts the treatment combination of elastic intramedullary nailing (ESIN), artificial bone substitute (Orthoss^®) and autologous platelet rich plasma, concentrated by the Gravitational Platelet Separation (GPS^®) - System. All patients were reviewed radiologically for one year following the removal of the intramedullary nailing, which was possible because of cyst obliteration.</p> <p>Results</p> <p>A cohort of 12 children (4 girls, 8 boys) was recruited. The mean patient age was 11.4 years (range 7-15 years). The bone defects (ten humeral, two femoral) included eight juvenile and four aneurysmal bone cysts. Five patients suffered from persistent cysts following earlier unsuccessful treatment of humeral bone cyst after pathologic fracture; the other seven presented with acute pathologic fractures. No peri- or postoperative complications occurred. The radiographic findings showed a total resolution of the cysts in ten cases (Capanna Grade 1); in two cases a small residual cyst remained (Capanna Grade 2). The intramedullary nails were removed six to twelve months (mean 7.7) after the operation; in one case, a fourteen year old boy (Capanna Grade 2), required a further application of GPS^®and Orthoss^®to reach a total resolution of the cyst. At follow-up (20-41 months, mean 31.8 months) all patients showed very good functional results and had returned to sporting activity. No refracture occurred, no further procedure was necessary.</p> <p>Conclusions</p> <p>The combination of elastic intramedullary nailing, artificial bone substitute and autologous platelet rich plasma (GPS^®) enhances the treatment of bone cysts in children, with no resulting complications.</p

Treatment for unicameral bone cysts in long bones: an evidence based review

The purpose of this paper is to perform an evidence based review for treatment of unicameral bone cysts. A search of MEDLINE (1966 to 2009) was conducted and the studies were classified according to levels of evidence. This review includes only comparative Level I-III studies. The systematic review identified 16 studies. There is one level I study, one level II study and the remaining 14 studies are level III. Seven of the sixteen studies had statistically different results: three studies indicated that steroid injection was superior to bone marrow injection or curettage and bone grafting; one study indicated that cannulated screws were superior to steroid injections; one study indicated resection and myoplasty was superior to steroid injection; one study indicated a combination of steroid, demineralized bone matrix and bone marrow aspirate, and curettage and bone grafting were superior to steroid injection; and one study indicated that curettage and bone grafting was superior to non-operative immobilization. Based on one Level I study, including a limited number of individuals, steroid injection seems to be superior to bone marrow injection. As steroid injections have already demonstrated superiority over bone marrow injections in a randomized clinical trial, the next step would be a prospective trial comparing steroid injections with other treatments.</p

The new Batch Mode Ion Source for stand-alone operation at the Facility for Rare Isotope Beams (FRIB)

Gas stoppers have been used for a long-standing successful science program at Michigan State University with stopped and rare-isotope beams produced by projectile fragmentation. The National Superconducting Cyclotron Laboratory’s Coupled Cyclotron Facility has recently transitioned into the Facility for Rare Isotope Beams (FRIB) laboratory to provide rare isotopes using a high-power superconducting linear accelerator and new production facilities. To allow the science program with stopped and reaccelerated beams to continue during the transition period, a stand-alone capability was added. The Batch Mode Ion Source (BMIS) was built and has been providing beams of long-lived and stable isotopes of a variety of elements for successful user experiments. The BMIS system is described and results from the production of various beams are presented